E. R. Dickson

1.2k total citations
14 papers, 912 citations indexed

About

E. R. Dickson is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. R. Dickson has authored 14 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. R. Dickson's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (2 papers). E. R. Dickson is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (2 papers). E. R. Dickson collaborates with scholars based in United States, Australia and Canada. E. R. Dickson's co-authors include R.E. Poupon, Karen Cauch‐Dudek, R Poupon, E. Jenny Heathcote, K. Lindor, Russell H. Wiesner, Ruud A. F. Krom, Michael K. Porayko, Sandra J. Beaver and J. Eileen Hay and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

E. R. Dickson

14 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. R. Dickson United States 9 667 544 303 181 77 14 912
Satoshi Nakano Japan 17 450 0.7× 381 0.7× 303 1.0× 125 0.7× 102 1.3× 57 850
R. P. Ng China 9 158 0.2× 224 0.4× 84 0.3× 167 0.9× 54 0.7× 17 617
Noritomo Shimada Japan 17 778 1.2× 608 1.1× 99 0.3× 92 0.5× 78 1.0× 58 935
Yasuaki Kuwata Japan 12 419 0.6× 240 0.4× 249 0.8× 182 1.0× 154 2.0× 31 699
L. A. Rybicki United States 9 266 0.4× 436 0.8× 141 0.5× 115 0.6× 67 0.9× 19 754
Jurgen Ludwig United States 12 730 1.1× 507 0.9× 517 1.7× 131 0.7× 81 1.1× 12 945
Scott M. Browning United States 9 124 0.2× 87 0.2× 346 1.1× 283 1.6× 155 2.0× 12 684
Shigeo Maruyama Japan 9 182 0.3× 188 0.3× 58 0.2× 46 0.3× 25 0.3× 25 378
Cheng-Chung Wu Taiwan 13 179 0.3× 162 0.3× 424 1.4× 214 1.2× 287 3.7× 38 744
Hiroaki Hazama Japan 12 241 0.4× 345 0.6× 153 0.5× 134 0.7× 84 1.1× 19 699

Countries citing papers authored by E. R. Dickson

Since Specialization
Citations

This map shows the geographic impact of E. R. Dickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. R. Dickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. R. Dickson more than expected).

Fields of papers citing papers by E. R. Dickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. R. Dickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. R. Dickson. The network helps show where E. R. Dickson may publish in the future.

Co-authorship network of co-authors of E. R. Dickson

This figure shows the co-authorship network connecting the top 25 collaborators of E. R. Dickson. A scholar is included among the top collaborators of E. R. Dickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. R. Dickson. E. R. Dickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Poterucha, John J., et al.. (2003). 759 Outcome of liver transplantation for hepatitis B in the U.S.. Hepatology. 38. 526–526. 4 indexed citations
2.
Weston, Shiobhan R., Roberta A. Jorgensen, E. R. Dickson, & Keith D. Lindor. (1999). Is Routine Cholangiography Useful in Men With Suspected Primary Biliary Cirrhosis?. Journal of Clinical Gastroenterology. 29(1). 68–70. 2 indexed citations
3.
Kim, W. Ray, et al.. (1998). The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis. Gastroenterology. 114. A1274–A1274. 4 indexed citations
4.
Poupon, R.E., K. Lindor, Karen Cauch‐Dudek, et al.. (1997). Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 113(3). 884–890. 457 indexed citations
5.
Therneau, Terry M., Russell H. Wiesner, Michael Malinchoc, et al.. (1997). A revised natural history model for primary sclerosing cholangitis obviates the need for liver histology. 2. 362. 8 indexed citations
6.
7.
Laurin, Jacqueline, et al.. (1994). The natural history of abdominal pain associated with primary biliary cirrhosis.. PubMed. 89(10). 1840–3. 19 indexed citations
8.
Porayko, Michael K., Russell H. Wiesner, J. Eileen Hay, et al.. (1991). Bone disease in liver transplant recipients: incidence, timing, and risk factors.. PubMed. 23(1 Pt 2). 1462–5. 140 indexed citations
9.
Fregeau, David R., Paul A. Davis, Dean J. Danner, et al.. (1989). Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha -ketoacid dehydrogenase complex.. The Journal of Immunology. 142(11). 3815–3820. 73 indexed citations
10.
Perkins, James D., Sylvester Sterioff, Russell H. Wiesner, et al.. (1987). Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.. PubMed. 19(1 Pt 3). 2434–6. 9 indexed citations
11.
Prochazka, Allan V., et al.. (1986). Primary thrombocythaemia treated with busulphan. British Journal of Haematology. 62(2). 229–237. 75 indexed citations
12.
Ludwig, J., et al.. (1984). Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases. 4(2). 1 indexed citations
13.
Dickson, E. R., Russell H. Wiesner, & W P Baldus. (1982). D-penicillamine improves survival and retards histologic progression in primary biliary cirrhosis. 82. 8 indexed citations
14.
Wiesner, Russell H., et al.. (1979). Pharmacokinetics of D-penicillamine in normals and primary biliary cirrhosis (PBC). 76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026